Could venous thromboembolism and major bleeding be indicators of lung cancer mortality? A nationwide database study.
Fiche publication
Date publication
mai 2020
Journal
BMC cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Dr FAGNONI Philippe, Dr FOUCHER Pascal, Pr QUANTIN Catherine
Tous les auteurs :
Howlett J, Benzenine E, Cottenet J, Foucher P, Fagnoni P, Quantin C
Lien Pubmed
Résumé
Venous thromboembolism (VTE) is highly prevalent in cancer patients and can cause severe morbidity. VTE treatment is essential, but anticoagulation increases the risk of major bleeding. The purpose was to evaluate the impact of VTE and major bleeding on survival and to identify significant risk factors for these events in lung cancer patients.
Mots clés
Anticoagulant therapy, Lung cancer, Major bleeding, Medico-administrative data, Venous thromboembolism
Référence
BMC Cancer. 2020 May 24;20(1):461